There are 2934 resources available
Introduction
Presenter: Aurélien Marabelle
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
Immunotherapy for locally advanced cancer
Presenter: Benjamin Besse
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
Turning cold into hot tumours
Presenter: Aurélien Marabelle
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
Role of imaging follow-up
Presenter: Virginie Westeel
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Role of patient reported outcome in patients' follow-up
Presenter: Paul van Schil
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
1691 - PARP inhibition increases immune infiltration in homologous recombination repair (HRR)-deficient tumors
Presenter: Benedetta Pellegrino
Session: Proffered Paper – Translational research
Resources:
Abstract
Slides
Webcast
2339 - Interferon ɣ (IFN-ɣ) gene signature and tryptophan 2,3-dioxygenase 2 (TDO2) gene expression: a potential predictive composite biomarker for linrodostat mesylate (BMS-986205; indoleamine 2,3-dioxygenase 1 inhibitor [IDO1i]) + nivolumab (NIVO)
Presenter: Jason Luke
Session: Proffered Paper – Translational research
Resources:
Abstract
Slides
Webcast
3661 - Long-term Outcomes from the Randomized Ph 2 Study of Nivolumab (nivo) or Nivo+Ipilimumab (ipi) in Patients (pts) with Melanoma Brain Metastases (mets): Anti-PD1 Brain Collaboration (ABC)
Presenter: Georgina Long
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
4844 - EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.
Presenter: Christopher Hoimes
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
4397 - An adaptive, biomarker directed platform study in metastatic urothelial cancer (BISCAY) with durvalumab in combination with targeted therapies
Presenter: Thomas Powles
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast